Earnings Scheduled For August 2, 2021
Companies Reporting Before The Bell
• HSBC Holdings (NYSE:HSBC) is estimated to report earnings for its second quarter.
Guggenheim Initiates Coverage On Ultragenyx Pharmaceutical with Neutral Rating
Guggenheim analyst Debjit Chattopadhyay initiates coverage on Ultragenyx Pharmaceutical (NASDAQ:RARE) with a Neutral rating.
Ultragenyx Pharmaceuticals Analyst Turns Bullish: What Investors Need To Know
A BofA Securities analyst is turning bullish on shares of Ultragenyx Pharmaceuticals (NASDAQ: RARE). Here's why.
The Ultragenyx Analyst: Tazeen Ahmad upgraded Ultragenyx from Neutral to Buy with a $162 price target.
B of A Securities Upgrades Ultragenyx Pharmaceutical to Buy, Announces $162 Price Target
B of A Securities analyst Tazeen Ahmad upgrades Ultragenyx Pharmaceutical (NASDAQ:RARE) from Neutral to Buy and announces $162 price target.
The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 13)
The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 10)
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came under pressure following the U.S.
Earnings Scheduled For May 4, 2021
Companies Reporting Before The Bell
• Lancaster Colony (NASDAQ:LANC) is likely to report quarterly earnings at $1.24 per share on revenue of $340.02 million.